By boosting the growth hormone levels, it could help enhance collagen production, leading to improved skin elasticity and firmness
Novo Nordisk is developing a high-dose oral form of semaglutide, but it hasnt yet been FDA-approved
The other usually cannot
Anecdotally, some users report experiencing gastrointestinal issues like nausea, diarrhea, or constipation, as well as headache, fatigue, or irritation at the injection site
Ozempic and Breastfeeding With PCOS: What You Need to Know It is not recommended when breastfeeding
Implications for the GLP-1 market: More employers will get ahead of the high costs associated with rising GLP-1 use by significantly restricting or eliminating coverage for the drugs, particularly as new oral formulations broaden their appeal